|
|
 The
outputs of our proprietary models allow to :
|
- Increase the commercial value
of an existing drugs Portfolio by enhancing therapeutic
potentials while diversifying domains of applications.
- Rescue molecules encountering
serious difficulties in late development phases.
- Accelerate the identification
and validation of physiologically coherent targets
and pharmacological interventions.
- Increase clinical trial success-rate
through the identification of inclusion / exclusion
criteria.
- Accelerate and streamline regulatory
processes by addressing key issues such as mechanisms
of drug action, drug interactions potential, etc...
- Identify, at early stages, development
programs that should be abandoned.
|
|
The characteristics of our interventions
|
- We target short term commercial
revenues for our clients.
- We ensure that implementation
of the solutions we propose will not require major
investments.
- We do not require our clients
to take more risks than they've already taken.
- To us, proposing a solution
implies that we are committed to share the risks
with our client.
|
Copyright © 2003 Bio-Modeling Systems / BMSystems. All rights reserved
bmsystems@bmsystems.net
|
